Not exact matches
As Poppe put it: «Valeant and the chief executive [Michael Pearson] had a good insight, which is that the
U.S. pharmaceutical industry was spending a lot of money on [
research and development] and not getting a great return on original
research and development ideas.»
With neurological disorders affecting approximately one - third of the
U.S. population, and
pharmaceutical firms largely abandoning their R&D efforts in neuroscience, the work of academic
research institutions such as CSHL is crucial in the effort to drive innovation and discovery in this field.»
As neurological disorders affect approximately one - third of the
U.S. population, and
pharmaceutical firms are largely abandoning their
research and development efforts in neuroscience, the work of academic
research institutions is crucial in the effort to drive innovation and discovery in this field.
According to a 2008 poll of
U.S. residents conducted by
Research!America, 94 % of Americans think universities and companies should work together to find new treatments, and 81 % think it's a good idea for
pharmaceutical companies to fund
research conducted in universities.
«
Research in Europe in the 1990s showed that pharmaceuticals were turning up in the water,» says Dana Kolpin, leader of a U.S. Geological Survey Water Resources Division research team that developed five new analytic methods for measuring water conta
Research in Europe in the 1990s showed that
pharmaceuticals were turning up in the water,» says Dana Kolpin, leader of a
U.S. Geological Survey Water Resources Division
research team that developed five new analytic methods for measuring water conta
research team that developed five new analytic methods for measuring water contaminants.
New
research has found that the
pharmaceuticals, which are frequently showing up in
U.S. streams, can alter genes responsible for building fish brains and controlling their behavior
But hard - core allopathic medicine has its own hall of shame: profit - driven
research that virtually ignores unpatentable plant - based medicines, antibiotic overkill that yields invulnerable super-pathogens, and — according to a lead article in the April 15, 1998 issue of the Journal of the American Medical Association — an estimated 100,000 deaths a year in
U.S. hospitals directly caused by adverse reactions to
pharmaceutical drugs.
But now several interested parties, including a major
pharmaceutical company and an ambitious
U.S. senator, are willing to back Briggs's continued
research.
In the
U.S., starting with the 1970s, the air and water quality has been dramatically improving; the number of people who smoke has dropped like a stone; the
pharmaceutical / medical / health care
research complex has produced wondrous solutions for communicable diseases; and yet, despite all that good news, the overall health of Americans and their lifespans have in some respects actually declined.
Five people, two of which former GlaxoSmithKline researchers, were charged with stealing cancer
research secrets from the British
pharmaceutical company according to indictments announced by the
U.S. Attorney's Office in Philadelphia last week.
Oversaw all trials conducted directly with
pharmaceutical companies as well as in partnership with McKesson
Pharmaceuticals U.S. Oncology
Research and the Midwest Melanoma Partnership.
His career has spanned working as a Director of Communications for a US - based
pharmaceutical / medical company, a
Research Analyst in the Biotechnology field, and 11 + years working for the Federal Government as a Foreign Service Officer for the
U.S. Department of State.